Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1

Mónica L. Fiszman, Marianna Di Egidio, Karina C. Ricart, Marisa G. Repetto, Laura N Borodinsky, Susana F. Llesuy, Roberto D. Saizar, Pedro L. Trigo, Symon Riedstra, Paulo P. Costa, Andrés M. Villa, Nestor Katz, Javier C. Lendoire, Roberto E P Sica

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: To evaluate the oxidative state in patients with familial amyloidotic polyneuropathy type 1 (FAP1). Design: From 3 unrelated families, patients with FAP1 carrying a transthyretin Met-30 mutation were studied. The diagnosis was confirmed by genetic analysis. Eleven of 21 patients carried the mutation; all were symptomatic and were clinically assessed using a clinical score. All of the patients were evaluated for copper-zinc superoxide dismutase type 1 activity in red blood cells using spectrophotometry. Plasma total reactive antioxidant potential was studied using a chemiluminescent method. The results were compared with those obtained from an age-matched control group. Setting: A public and academic multidisciplinary research clinic. Results: Six of the 11 FAP1-positive patients disclosed superoxide dismutase type 1 activity values greater than 55 U/mg of protein (upper control limit), whereas 9 of 10 patients in whom total reactive antioxidant potential was measured had values below the lower limit of the control group. No relationship was found between the levels of superoxide dismutase type 1 activity and the severity of the clinical involvement. Conclusions: Oxidative stress may be part of the mechanisms leading to tissue damage in patients with FAP1. The lack of correlation between the laboratory findings and the severity of clinical involvement may signal that oxidative processes are at work throughout the natural history of the disease.

Original languageEnglish (US)
Pages (from-to)593-597
Number of pages5
JournalArchives of Neurology
Volume60
Issue number4
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Polyneuropathies
Oxidative Stress
Antioxidants
Control Groups
Mutation
Spectrophotometry
Familial
Zinc
Copper
Research Design
Erythrocytes
Research
Superoxide Dismutase-1

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Fiszman, M. L., Di Egidio, M., Ricart, K. C., Repetto, M. G., Borodinsky, L. N., Llesuy, S. F., ... Sica, R. E. P. (2003). Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1. Archives of Neurology, 60(4), 593-597. https://doi.org/10.1001/archneur.60.4.593

Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1. / Fiszman, Mónica L.; Di Egidio, Marianna; Ricart, Karina C.; Repetto, Marisa G.; Borodinsky, Laura N; Llesuy, Susana F.; Saizar, Roberto D.; Trigo, Pedro L.; Riedstra, Symon; Costa, Paulo P.; Villa, Andrés M.; Katz, Nestor; Lendoire, Javier C.; Sica, Roberto E P.

In: Archives of Neurology, Vol. 60, No. 4, 01.04.2003, p. 593-597.

Research output: Contribution to journalArticle

Fiszman, ML, Di Egidio, M, Ricart, KC, Repetto, MG, Borodinsky, LN, Llesuy, SF, Saizar, RD, Trigo, PL, Riedstra, S, Costa, PP, Villa, AM, Katz, N, Lendoire, JC & Sica, REP 2003, 'Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1', Archives of Neurology, vol. 60, no. 4, pp. 593-597. https://doi.org/10.1001/archneur.60.4.593
Fiszman, Mónica L. ; Di Egidio, Marianna ; Ricart, Karina C. ; Repetto, Marisa G. ; Borodinsky, Laura N ; Llesuy, Susana F. ; Saizar, Roberto D. ; Trigo, Pedro L. ; Riedstra, Symon ; Costa, Paulo P. ; Villa, Andrés M. ; Katz, Nestor ; Lendoire, Javier C. ; Sica, Roberto E P. / Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1. In: Archives of Neurology. 2003 ; Vol. 60, No. 4. pp. 593-597.
@article{c97ad4ff0d824b9c8e979f40759ba200,
title = "Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1",
abstract = "Objective: To evaluate the oxidative state in patients with familial amyloidotic polyneuropathy type 1 (FAP1). Design: From 3 unrelated families, patients with FAP1 carrying a transthyretin Met-30 mutation were studied. The diagnosis was confirmed by genetic analysis. Eleven of 21 patients carried the mutation; all were symptomatic and were clinically assessed using a clinical score. All of the patients were evaluated for copper-zinc superoxide dismutase type 1 activity in red blood cells using spectrophotometry. Plasma total reactive antioxidant potential was studied using a chemiluminescent method. The results were compared with those obtained from an age-matched control group. Setting: A public and academic multidisciplinary research clinic. Results: Six of the 11 FAP1-positive patients disclosed superoxide dismutase type 1 activity values greater than 55 U/mg of protein (upper control limit), whereas 9 of 10 patients in whom total reactive antioxidant potential was measured had values below the lower limit of the control group. No relationship was found between the levels of superoxide dismutase type 1 activity and the severity of the clinical involvement. Conclusions: Oxidative stress may be part of the mechanisms leading to tissue damage in patients with FAP1. The lack of correlation between the laboratory findings and the severity of clinical involvement may signal that oxidative processes are at work throughout the natural history of the disease.",
author = "Fiszman, {M{\'o}nica L.} and {Di Egidio}, Marianna and Ricart, {Karina C.} and Repetto, {Marisa G.} and Borodinsky, {Laura N} and Llesuy, {Susana F.} and Saizar, {Roberto D.} and Trigo, {Pedro L.} and Symon Riedstra and Costa, {Paulo P.} and Villa, {Andr{\'e}s M.} and Nestor Katz and Lendoire, {Javier C.} and Sica, {Roberto E P}",
year = "2003",
month = "4",
day = "1",
doi = "10.1001/archneur.60.4.593",
language = "English (US)",
volume = "60",
pages = "593--597",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Evidence of oxidative stress in familial amyloidotic polyneuropathy type 1

AU - Fiszman, Mónica L.

AU - Di Egidio, Marianna

AU - Ricart, Karina C.

AU - Repetto, Marisa G.

AU - Borodinsky, Laura N

AU - Llesuy, Susana F.

AU - Saizar, Roberto D.

AU - Trigo, Pedro L.

AU - Riedstra, Symon

AU - Costa, Paulo P.

AU - Villa, Andrés M.

AU - Katz, Nestor

AU - Lendoire, Javier C.

AU - Sica, Roberto E P

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Objective: To evaluate the oxidative state in patients with familial amyloidotic polyneuropathy type 1 (FAP1). Design: From 3 unrelated families, patients with FAP1 carrying a transthyretin Met-30 mutation were studied. The diagnosis was confirmed by genetic analysis. Eleven of 21 patients carried the mutation; all were symptomatic and were clinically assessed using a clinical score. All of the patients were evaluated for copper-zinc superoxide dismutase type 1 activity in red blood cells using spectrophotometry. Plasma total reactive antioxidant potential was studied using a chemiluminescent method. The results were compared with those obtained from an age-matched control group. Setting: A public and academic multidisciplinary research clinic. Results: Six of the 11 FAP1-positive patients disclosed superoxide dismutase type 1 activity values greater than 55 U/mg of protein (upper control limit), whereas 9 of 10 patients in whom total reactive antioxidant potential was measured had values below the lower limit of the control group. No relationship was found between the levels of superoxide dismutase type 1 activity and the severity of the clinical involvement. Conclusions: Oxidative stress may be part of the mechanisms leading to tissue damage in patients with FAP1. The lack of correlation between the laboratory findings and the severity of clinical involvement may signal that oxidative processes are at work throughout the natural history of the disease.

AB - Objective: To evaluate the oxidative state in patients with familial amyloidotic polyneuropathy type 1 (FAP1). Design: From 3 unrelated families, patients with FAP1 carrying a transthyretin Met-30 mutation were studied. The diagnosis was confirmed by genetic analysis. Eleven of 21 patients carried the mutation; all were symptomatic and were clinically assessed using a clinical score. All of the patients were evaluated for copper-zinc superoxide dismutase type 1 activity in red blood cells using spectrophotometry. Plasma total reactive antioxidant potential was studied using a chemiluminescent method. The results were compared with those obtained from an age-matched control group. Setting: A public and academic multidisciplinary research clinic. Results: Six of the 11 FAP1-positive patients disclosed superoxide dismutase type 1 activity values greater than 55 U/mg of protein (upper control limit), whereas 9 of 10 patients in whom total reactive antioxidant potential was measured had values below the lower limit of the control group. No relationship was found between the levels of superoxide dismutase type 1 activity and the severity of the clinical involvement. Conclusions: Oxidative stress may be part of the mechanisms leading to tissue damage in patients with FAP1. The lack of correlation between the laboratory findings and the severity of clinical involvement may signal that oxidative processes are at work throughout the natural history of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0344406277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344406277&partnerID=8YFLogxK

U2 - 10.1001/archneur.60.4.593

DO - 10.1001/archneur.60.4.593

M3 - Article

C2 - 12707074

AN - SCOPUS:0344406277

VL - 60

SP - 593

EP - 597

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 4

ER -